Smart for Life Announces LOI to Acquire State-of-the-Art Manufacturer of Vitamins and Supplements

Rhea-AI Summary

Smart for Life, Inc. (Nasdaq: SMFL) has executed a Letter of Intent to acquire a manufacturer of vitamins and supplements, expecting to add an estimated $20 million of revenue on a pro forma basis. The acquisition aligns with the company's M&A strategy in the nutraceutical space and aims to bring significant manufacturing capabilities in the health and wellness sector. Smart for Life is targeting $100 million in revenue, and this acquisition is expected to be the largest to date.

Acquisition is Expected to Add an Estimated $20 Million of Revenue on a Pro Forma Basis and Provide Significantly Enhanced Manufacturing Capabilities

MIAMI, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it has executed a Letter of Intent (LOI) to acquire a state-of-the-art manufacturer of vitamins and supplements, which is expected to add an estimated $20 million of revenue on a pro forma basis over the next year.

“We are pleased to announce this latest LOI as part of our M&A strategy in the nutraceutical space,” said A.J. Cervantes, Jr., the Company’s Chairman. “This transaction will be our largest acquisition to date. Upon closing, Smart for Life will be continuing our mission of acquiring complementary businesses at attractive valuations, especially as we grow toward our stated goal of $100 million in revenue.”

“This target acquisition brings significant manufacturing capabilities in the health and wellness sector and should be highly synergistic with our existing channels and brands,” stated Darren Minton, CEO of Smart for Life. “In addition, the company is already audited by a top ten PCAOB accounting firm, which will significantly streamline the due diligence phase, in addition to the overall speed of the transaction. Moreover, we believe Smart for Life can achieve meaningful operating efficiencies by bringing additional capabilities in-house, making this acquisition highly accretive. We look forward to sharing additional information as we complete due diligence and definitive documentation over the coming weeks.”

Completion of the acquisition is subject to completion of due diligence and other closing conditions.

About Smart for Life, Inc.

Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition/Sports Illustrated Nutrition and Ceautamed Worldwide/Greens First. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Forward-Looking Statements

This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Investor Relations Contact

Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

FAQ

What is the latest announcement from Smart for Life, Inc. (Nasdaq: SMFL)?

Smart for Life, Inc. (Nasdaq: SMFL) has executed a Letter of Intent to acquire a state-of-the-art manufacturer of vitamins and supplements.

What is the expected revenue addition from the acquisition?

The acquisition is expected to add an estimated $20 million of revenue on a pro forma basis over the next year.

What is the goal of Smart for Life, Inc. (Nasdaq: SMFL) in terms of revenue?

Smart for Life aims to grow toward its stated goal of $100 million in revenue.

What are the potential benefits of the acquisition for Smart for Life, Inc. (Nasdaq: SMFL)?

The acquisition is expected to bring significant manufacturing capabilities in the health and wellness sector and is highly synergistic with the company's existing channels and brands.

What are the conditions for completion of the acquisition?

Completion of the acquisition is subject to completion of due diligence and other closing conditions.